(TEVA) Teva Pharmaceuticals – Bull of the Day

January 21st, 2010

Teva Pharmaceuticals (TEVA) reported earnings of $0.89 in the third quarter of 2009, up 16% from the year-ago period and a cent above the Zacks Consensus Estimate. Net sales increased 25% to $3.55 billion.

We are impressed with Teva’s strong performance in the first nine months of 2009. We expect Teva to continue posting strong revenues and earnings going forward thanks to new product launches, both generic and branded. We are also pleased to see Teva’s progress with its branded and biogenerics pipeline. Biogenerics should help drive growth in the long-term.

Meanwhile, the acquisition of Barr should help Teva strengthen its position in the U.S. and expand its presence in Europe. We are maintaining our Outperform recommendation on Teva with a price target of $65.

Zacks Investment Research

More on this topic (What's this?)
The Complete List of Israeli Stocks Traded in the U.S. (Top Foreign Stocks, 12/5/09)
Thursday's Hot Stocks: Selling Time on Valeant Pharmaceuticals (Hot Trading Strategies For A Col..., 1/8/10)
Teva Pharmaceutical: A Fair Price (Bullish Bankers, 3/10/10)
TEVA (All Allan, 4/15/10)
Read more on Pharmaceuticals, Teva Pharmaceutical Industries at Wikinvest

Related Posts:

  1. (TEVA) Teva Pharmaceutical Industries Outlines Long-Term GoalsTeva Pharmaceutical Industries Ltd. (TEVA) recently presented an update on its long-term goals and stated...
  2. (TEVA) Teva Pharmaceuticals Industries-AstraZeneca Settle DisputeGeneric player, Teva Pharmaceuticals Industries Ltd. (TEVA) recently settled its patent dispute with AstraZeneca (AZN)...
  3. (TEVA) Teva Pharmaceutical Industries Bolsters Position in JapanGeneric player Teva Pharmaceutical Industries Ltd. (TEVA) recently announced that its joint venture in Japan...
  4. (TEVA) Teva Pharmaceutical Expands Cancer PortfolioIn a move to expand its branded product offering, generic player Teva Pharmaceutical Industries Ltd....
  5. (CEPH) Cephalon Inc Sues Teva PharmaceuticalsRecently, Cephalon, Inc. (CEPH) filed a patent infringement lawsuit against generic player Teva Pharmaceuticals (TEVA),...
  6. (TEVA) Teva Pharmaceuticals’ Copaxone ChallengedShares of generic player Teva Pharmaceuticals, Inc. (TEVA) were down approximately 2% on news regarding...


Search Posts by Tag: | | Drug Manufacturers - Other | Healthcare

RSS Feeds by Tag: TEVA | Teva Pharmaceutical Industries Limited | Drug Manufacturers - Other | Healthcare |

Other Posts by: | RSS Feed for this author